COSCIENS BIOPHARMA INC (CSCIF:OTCMKTS)
$2.03 0 (0%)
Analysed COSCIENS BIOPHARMA INC (CSCIF:OTCMKTS) News Sources
COSCIENS Biopharma Inc. Provides Update on its Plan to Suspend U.S. Public Company Reporting Obligations
20-04-2026
yahoo.com
COSCIENS Comments on Unusual Market Activity
07-04-2026
yahoo.com
COSCIENS Biopharma: Q4 Earnings Snapshot
25-03-2026
yahoo.com
COSCIENS Biopharma Inc. Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
25-03-2026
yahoo.com
Upcoming Meeting Dates - March 23, 2026
23-03-2026
yahoo.com
COSCIENS Biopharma to Stop Funding Aeterna Zentaris GmbH and Zentaris IVF GmbH
06-03-2026
yahoo.com
COSCIENS Provides Strategic Update
05-03-2026
yahoo.com
COSCIENS Announces Exclusive Distribution Agreement with Wuzhou Drug International for Macrilen® in Hainan-Guangdong-Hong Kong-Macao Greater Bay Area and Singapore
01-12-2025
yahoo.com
COSCIENS Biopharma Inc. Announces Leadership Change
14-11-2025
yahoo.com
COSCIENS Biopharma: Q3 Earnings Snapshot
11-11-2025
yahoo.com
What is the current price of COSCIENS BIOPHARMA INC (CSCIF:OTCMKTS)?
The current price of COSCIENS BIOPHARMA INC (CSCIF:OTCMKTS) is $2.03.
COSCIENS BIOPHARMA INC (CSCIF:OTCMKTS) absolute price change since previous trading day?
The absolute price change of COSCIENS BIOPHARMA INC (CSCIF:OTCMKTS) since the previous trading day is $0.
COSCIENS BIOPHARMA INC (CSCIF:OTCMKTS) percentage price change since previous trading day?
The percentage price change of COSCIENS BIOPHARMA INC (CSCIF:OTCMKTS) since the previous trading day is 0%.
What is the most recent average sentiment score for COSCIENS BIOPHARMA INC (CSCIF:OTCMKTS)?
The most recent average sentiment score for COSCIENS BIOPHARMA INC (CSCIF:OTCMKTS) is 41 out of 100.
What is the most recent average sentiment for COSCIENS BIOPHARMA INC (CSCIF:OTCMKTS)?
The most recent sentiment for COSCIENS BIOPHARMA INC (CSCIF:OTCMKTS) is .
SEC-8K** Filing Available For COSCIENS BIOPHARMA INC (CSCIF:OTCMKTS)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.